NASDAQ: HCWB - HCW Biologics Inc.

Lønnsomhet i seks måneder: -32.26%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan HCW Biologics Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet HCW Biologics Inc.

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases.

flere detaljer
It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-07-20
ISIN US40423R1059
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.hcwbiologics.com
Цена ао 1.7
Prisendring per dag: +0.4785% (0.418)
Prisendring per uke: -6.46% (0.449)
Prisendring per måned: -16.35% (0.5021)
Prisendring over 3 måneder: -17.86% (0.5113)
Prisendring over seks måneder: -32.26% (0.62)
Prisendring per år: -65.71% (1.225)
Prisendring over 3 år: -82.79% (2.44)
Prisendring over 5 år: 0% (0.42)
Prisendring over 10 år: 0% (0.42)
Prisendring siden begynnelsen av året: +42.57% (0.2946)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 14.29 1
P/BV 3.02 5
P/E 0 0
EV/EBITDA -1.77 0
Total: 4.13

Effektivitet

Navn Betydning Karakter
ROA, % -87.66 0
ROE, % -185.67 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.2624 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -30.69 0
Lønnsomhet Ebitda, % 241.68 10
Lønnsomhet EPS, % 135.33 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 205142 0.54
HighTower Advisors, LLC 179810 0.48
Avantax Planning Partners, Inc. 179541 0.47
Geode Capital Management, LLC 134436 0.36
Cresset Asset Management, LLC 131990 0.35
Bridgeway Capital Management, Inc. 84700 0.22
Blackrock Inc. 47158 0.12
AE Wealth Management LLC 30000 0.08
Two Sigma Investments, LP 22640 0.06
State Street Corporation 21446 0.06

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00277 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Hing C. Wong Ph.D. Founder, CEO, Director & Secretary 425.88k 1954 (71 år)
Ms. Rebecca Byam CPA, M.B.A. Chief Financial Officer 300.3k 1956 (69 år)
Dr. Peter Rhode Ph.D. Chief Scientific Officer & VP of Clinical Operations 251.16k 1958 (67 år)
Ms. Nicole Valdivieso Esq. Vice President of Legal Affairs N/A
Mr. Lee D. Flowers Senior Vice President of Business Development N/A 1946 (79 år)

Adresse: United States, Miramar. FL, 2929 North Commerce Parkway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.hcwbiologics.com